Additional Effect of Wound Infiltration After Cesarean Section With Optimal Standard Analgesia (KTcesar)
Postoperative Pain, Anesthesia, Local, Breast Feeding
About this trial
This is an interventional treatment trial for Postoperative Pain focused on measuring Postcesarean Section, Postoperative Pain, Care, Postoperative, Anesthesia, Local, Breast Feeding, Morphine, Pain Measurement, levobupivacaine
Eligibility Criteria
Inclusion Criteria:
- Scheduled cesarean section
Exclusion Criteria:
- Emergency cesarean section
- Contraindication to opioids, paracetamol, or local anaesthetic
- Ongoing infection
- Coagulation disorders
- Diabetes treated with insulin
- Chronic opioid use
Sites / Locations
- Poissy Saint Germain en Laye Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Continuous wound infiltration
Control
Subfascial continuous wound infiltration with Levobupivacaine: bolus 50mg and 6.25mg/h for 48 hours through a multiperforated catheter, in addition to Celecoxib 200mg twice a day, paracetamol 1g four times a day, Nefopam 20mg four times a day, and intravenous morphine for 24 hours with Patient Controlled Analgesia pump (1.2mg by bolus, 7 minutes lockout period).
Celecoxib 200mg twice a day, paracetamol 1g four times a day, Nefopam 20mg four times a day, and intravenous morphine for 24 hours with Patient Controlled Analgesia pump (1.2mg by bolus, 7 minutes lockout period).